Bottom line
Is DTSVX a good fund? The bottom line
DTSVX is the Investment Class share class of Small Company Value Portfolio, an actively managed small-cap mutual fund from Wilshire Mutual.
Its expense ratio is 1.35% — about $135 a year on every $10,000 invested, more expensive than 80% of small-cap funds we track.
It returned +10.4% over one year, +10.5% a year over five years, +8.6% a year over ten (as of Dec 31, 2025, per its prospectus).
With $25.3 million in net assets and 681 holdings, its largest position is Astrana Health Inc (2.0%) and the top 10 make up 13.6% of the portfolio.
What stands out
- 5-year return beat 86% of category peers
- Broadly diversified (681 holdings)
What to watch
- Expensive for its category (1.35%)
- 12b-1 marketing fee of 0.25% a year
- Small fund ($25.3 million) — small funds are likelier to close
Updated Nov 19, 2026
What DTSVX invests in
The Small Company Value Portfolios (the Portfolio) investment objective is to seek capital appreciation.
The Portfolio invests substantially all of its assets in the common stock of companies with smaller market capitalizationsgenerally within the range of companies comprising the Russell 2000 Value Index (as of December 31, 2025, this range was between approximately $4.96 million and $31.29 billion) at the time of purchase. The market capitalization range and composition of the companies in the Russell 2000 Value Index are subject to change. The Portfolio invests, generally, in companies with relatively low price to book value ratios, relatively low price to earnings ratios and relatively high dividend yields (dividend yields for small companies are generally less than those of large companies). The Portfolio uses a multi-manager strategy where multiple subadvisers employ different strategies with respect to separate portions of the Portfolio in order achieve the Portfolios investment…
From the fund's prospectus (filed Apr 29, 2026).
DTSVX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| DTSVX | +10.4% | +10.5% | +8.6% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What DTSVX costs
On a $10,000 investment, DTSVX's 1.35% expense ratio costs about $135 a year. The prospectus estimates $2,285 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
DTSVX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Astrana Health Inc ASTH | 1.97% |
| 2 | Triumph Financial Inc TFIN | 1.59% |
| 3 | Red Rock Resorts Inc RRR | 1.49% |
| 4 | Ryman Hospitality Properties I RHP | 1.46% |
| 5 | Ducommun Inc DCO | 1.43% |
| 6 | UFP Technologies Inc UFPT | 1.22% |
| 7 | Bank OZK OZK | 1.17% |
| 8 | Magnolia Oil & Gas Corp MGY | 1.13% |
| 9 | Mesa Laboratories Inc MLAB | 1.11% |
| 10 | Utz Brands Inc UTZ | 1.03% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 13.6% of the fund. See all top 25 holdings and asset mix →